ADCT ADC Therapeutics SA
2026Q1 · CUSIP H0036K147 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
117
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
64
Δ whales
+2
Inst. holding value
$311M
New positions
19
Closed positions
17
Price momentum (1Q)
—
Put / Call
0/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 19% | — | — |
| 2024Q2 | Top 5% | — | — |
| 2022Q2 | Top 11% | — | — |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
4
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.97
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+4.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)